NL-OMON20323
Not yet recruiting
Not Applicable
Serum Amyloid A as a prognostic marker for disease severity and mortality in COVID-19
Board of Directors Franciscus Gasthuis & Vlietland0 sites350 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Board of Directors Franciscus Gasthuis & Vlietland
- Enrollment
- 350
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •18 jaar or older;
- •hospitalised for (suspicion of) COVID\-19;
- •written informed consent for those subjects admitted to the non\-ICU clinical COVID\-19 ward.
Exclusion Criteria
- •Subjects undergoing experimental interventions will be excluded.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Serum Amyloid A as a prognostic marker for disease severity and mortality in COVID-19NL-OMON51218Franciscus Gasthuis & Vlietland150
Completed
Not Applicable
The Diagnostic and Prognostic Role of SAA in Intrathoracic SarcoidosisSarcoidosis, PulmonaryNCT05811962University Medical Centre Ljubljana135
Completed
Phase 4
The clinical prognostic value of amyloid imaging with [18F]AV-45 in a subjects with subjective complaintsAlzheimer's Diseasedementia of the Alzheimer type1002930510012272NL-OMON47767Vrije Universiteit Medisch Centrum280
Recruiting
Phase 2
Plasma biomarker reflecting cerebral amyloid deposition: a multicenter study for the clinical applicatioAlzheimer's disease Other Dementia Mild cognitive impairment (MCI) Healthy volunteerJPRN-UMIN000023976ational Center for Geriatrics and Gerontology400
Unknown
Not Applicable
Maternal Serum Amyloid A Levels in Pregnancies Complicated With Preterm Labour.Preterm LaborNCT03205020mona nematallah58